StockData
Zomedica Corp. logo

Zomedica Corp. (ZOMDF) shareholders

ZOMDFOTCPharmaceutical PreparationsFiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 4, 2026Score 10/30
$0.08−0.00 (-0.55%)

Close on Oct 19, 2026Market cap $77.40MP/E –Yield –

Ownership

Institutional holdings as of Jun 30, 2026, from 13F filings

Held by institutions
0.0%
0M of 980M shares
Institutional holders
7
2 new, 3 sold out
Net institutional buying
-1M
In Q2 2026
Insider trades, 12 months
12 buys · 0 sales
Net bought $169.76K

Shares held by institutions

Top institutional holders

13F holdings as of Jun 30, 2026

HolderShares% of ZOMDFValueChange% of portfolio
Ancora Advisors, LLC83,6100.01%$8.35K–0.00%
CoreCap Advisors, LLC4,8000.00%$480–0.00%
Gill Capital Partners, LLC2,7190.00%$272–0.00%
Harbour Investments, Inc.2,2000.00%$220–0.00%
EverSource Wealth Advisors, LLC1,0000.00%$100New0.00%
Bogart Wealth, LLC6800.00%$68–0.00%
Farther Finance Advisors, LLC860.00%$9New0.00%

Institutional buying and selling by quarter

Positions opened, added to, reduced and closed by 13F filers

QuarterHoldersShares held% of sharesNew / addedReduced / closedShares boughtShares sold
Q2 202670M0.0%2 / 00 / 30M1M
Q1 202681M0.1%2 / 21 / 10M0M
Q4 202571M0.1%1 / 02 / 30M1M
Q3 202592M0.2%2 / 02 / 31M4M
Q2 2025105M0.5%2 / 12 / 140M1M
Q1 2025237M0.7%3 / 31 / 725M90M
Q4 20249292M9.4%17 / 1710 / 912M1M
Q3 20248581M8.3%9 / 1315 / 1911M4M
Q2 20249785M8.6%13 / 1517 / 134M5M
Q1 20249885M8.7%15 / 1321 / 103M7M
Q4 20239389M9.1%17 / 209 / 126M1M
Q3 20238884M8.6%8 / 2010 / 131M14M

Officers, directors and major owners

People who filed Forms 3, 4 or 5 in the last two years

NameRoleShares owned% of sharesLatest filing
Larry C. Heaton IiCEO, Director1,250,0000.13%Nov 9, 2026
Anthony K. BlairCOO1,000,0000.10%Aug 7, 2026
Karen DeHaan-FullertonGeneral Counsel104,3000.01%Aug 7, 2026
Russell Kevin KlassSr Vice President, Sales6,105,0000.62%Aug 7, 2026
Scott JordanChief Financial Officer300,0000.03%Mar 19, 2025
Christopher Ross MacleodDirector143,0000.01%Nov 17, 2026
Pamela NicholsDirector––Nov 17, 2026
Sean WhelanDirector––Nov 17, 2026
Johnny D. PowersDirector4,425,0000.45%Nov 17, 2026
Jeffrey M. RoweDirector13,116,1271.34%Nov 17, 2026
Robert CohenDirector543,7500.06%Nov 17, 2026
Rodney James WilliamsDirector301,9000.03%Nov 18, 2025

Insider trades

Common stock transactions reported on Form 4, newest first

InsiderDateTransactionSharesPriceValueShares after
Russell Kevin Klass
Sr. Vice President, Sales
May 21, 2026Buy+104,000$0.10$10.40K104,000
Russell Kevin Klass
–
May 21, 2026Buy+11,399$0.11$1.25K5,995,500
Russell Kevin Klass
–
May 21, 2026Buy+5,500$0.11$6056,001,000
Johnny D. Powers
Director
May 20, 2026Buy+97,515$0.10$9.75K4,425,000
Russell Kevin Klass
–
May 20, 2026Buy+200,000$0.11$22.00K5,984,101
Johnny D. Powers
Director
May 19, 2026Buy+2,485$0.10$2494,327,485
Johnny D. Powers
Director
May 18, 2026Buy+100,000$0.10$10.00K4,325,000
Johnny D. Powers
Director
May 13, 2026Buy+200,000$0.11$22.00K4,225,000
Johnny D. Powers
Director
May 12, 2026Buy+100,000$0.11$11.00K4,025,000
Johnny D. Powers
Director
May 11, 2026Buy+391,129$0.11$43.02K3,925,000
Johnny D. Powers
Director
May 8, 2026Buy+108,871$0.11$11.98K3,533,871
Larry C. Heaton Ii
CEO, Director
May 8, 2026Buy+250,000$0.11$27.50K1,250,000
Russell Kevin Klass
Sr Vice President, Sales
Nov 13, 2025Buy+150,000$0.10$15.00K5,784,101
Russell Kevin Klass
Sr Vice President, Sales
Nov 10, 2025Buy+120,000$0.10$12.00K5,634,101
Russell Kevin Klass
Sr Vice President, Sales
Nov 7, 2025Buy+5,000$0.10$5005,514,101
Russell Kevin Klass
Sr Vice President, Sales
Nov 6, 2025Buy+253,007$0.08$20.24K5,509,101
Russell Kevin Klass
Sr Vice President, Sales
Aug 12, 2025Buy+745,341$0.04$29.81K5,256,094
Russell Kevin Klass
Sr Vice President, Sales
Aug 12, 2025Buy+250,000$0.04$10.00K4,510,753
Russell Kevin Klass
Sr Vice President, Sales
Aug 11, 2025Buy+60,723$0.04$2.43K4,260,753
Russell Kevin Klass
Sr Vice President of Sales
Aug 11, 2025Buy+250,000$0.04$10.00K3,950,030
Russell Kevin Klass
Sr Vice President of Sales
Aug 11, 2025Buy+250,000$0.04$10.00K4,200,030
Russell Kevin Klass
Sr Vice President of Sales
Aug 8, 2025Buy+500,000$0.04$20.00K3,700,030
Anthony K. Blair
COO
May 21, 2025Buy+63,750$0.05$3.19K1,000,000
Anthony K. Blair
COO
May 21, 2025Buy+36,250$0.05$1.81K936,250
Johnny D. Powers
Director
May 19, 2025Buy+500,000$0.05$25.00K3,425,000
Karen DeHaan-Fullerton
General Counsel/Corporate Secy
May 19, 2025Buy+104,300$0.05$5.22K104,300
Jeffrey M. Rowe
Director
Mar 17, 2025Buy+100,647$0.07$7.05K1,540,127
Jeffrey M. Rowe
Director
Mar 17, 2025Buy+500,000$0.06$30.00K1,439,480
Jeffrey M. Rowe
Director
Mar 17, 2025Buy+731,368$0.07$51.20K2,399,495
Jeffrey M. Rowe
Director
Mar 17, 2025Buy+4,265$0.07$2992,343,760
Jeffrey M. Rowe
Director
Mar 17, 2025Buy+34,725$0.07$2.43K2,378,485
Jeffrey M. Rowe
Director
Mar 17, 2025Buy+68,000$0.07$4.76K1,608,127
Rodney James Williams
Director
Mar 17, 2025Buy+100,000$0.07$7.00K261,900
Scott Jordan
Chief Financial Officer
Mar 17, 2025Buy+300,000$0.06$18.00K300,000
Rodney James Williams
Director
Mar 17, 2025Buy+100,000$0.07$7.00K100,000
Russell Kevin Klass
Sr Vice President of Sales
Mar 17, 2025Buy+699,980$0.07$49.00K3,200,030
Jeffrey M. Rowe
Director
Mar 17, 2025Buy+500,000$0.06$30.00K775,000
Jeffrey M. Rowe
Director
Mar 17, 2025Buy+100,647$0.07$7.05K875,647
Jeffrey M. Rowe
Director
Mar 17, 2025Buy+68,000$0.07$4.76K943,647
Jeffrey M. Rowe
Director
Mar 17, 2025Buy+731,368$0.07$51.20K1,675,015
Jeffrey M. Rowe
Director
Mar 17, 2025Buy+34,725$0.07$2.43K1,714,005
Jeffrey M. Rowe
Director
Mar 17, 2025Buy+4,265$0.07$2991,679,280
Johnny D. Powers
Director
Mar 17, 2025Buy+100,000$0.07$7.00K2,925,000
Johnny D. Powers
Director
Mar 17, 2025Buy+50,000$0.07$3.50K2,825,000
Johnny D. Powers
Director
Mar 17, 2025Buy+100,000$0.07$7.00K2,775,000
Johnny D. Powers
Director
Mar 17, 2025Buy+100,000$0.07$7.00K2,675,000
Johnny D. Powers
Director
Mar 17, 2025Buy+50,000$0.07$3.50K2,575,000
Johnny D. Powers
Director
Mar 17, 2025Buy+100,000$0.07$7.00K2,525,000
Christopher Ross Macleod
Director
Mar 17, 2025Buy+143,000$0.06$8.58K143,000
Anthony K. Blair
COO
Mar 17, 2025Buy+500,000$0.06$30.00K900,000
Larry C. Heaton Ii
CEO, Director
Mar 17, 2025Buy+118,855$0.06$7.13K628,855
Larry C. Heaton Ii
CEO, Director
Mar 17, 2025Buy+191,817$0.06$11.51K820,672
Larry C. Heaton Ii
CEO, Director
Mar 17, 2025Buy+179,328$0.06$10.76K1,000,000
Larry C. Heaton Ii
CEO, Director
Mar 17, 2025Buy+10,000$0.05$500510,000
Russell Kevin Klass
Vice President of Sales
Nov 11, 2024Buy+289,800$0.12$34.78K1,500,050
Russell Kevin Klass
Vice President of Sales
Nov 11, 2024Buy+210,200$0.12$25.22K1,210,250
Larry C. Heaton Ii
CEO, Director
Nov 11, 2024Buy+100,000$0.12$12.00K500,000
Johnny D. Powers
Director
Nov 11, 2024Buy+100,000$0.12$12.00K2,425,000
Anthony K. Blair
COO
Nov 8, 2024Buy+150,000$0.12$18.00K400,000
Larry C. Heaton Ii
CEO, Director
Sep 5, 2024Buy+100,000$0.13$13.00K400,000

Awards, option exercises, tax withholding and gifts are shown alongside open-market buys and sales. Each name links to the filing on SEC EDGAR.

Short interest

Shares sold short and not yet bought back, as of Oct 30, 2026 (FINRA, reported twice a month)

Short % of shares outstanding
–
0M shares short
Days to cover
1.0
At 2M shares a day
Change since last report
-88.1%
From 0M shares
Short volume, 0 days
–
Of volume reported to FINRA

Shares sold short, last 12 months

Short sale volume counts trades marked short on any given day, including market-maker hedging, so it runs far higher than the share of Zomedica's stock actually held short. Settlement fails (shares not delivered on time) peaked at 3,723 shares on Aug 25, 2026 over the last 90 days.

See a number that looks wrong?